Chronic diarrhoea and fatty stools

Published on 13/02/2015 by admin

Filed under Gastroenterology and Hepatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2020 times

14 Chronic diarrhoea and fatty stools

Case

A 48-year-old man presents with a history of frequent watery diarrhoea for the last 3 months, up to six times daily. He travelled to Southeast Asia, including Thailand, 3 months ago. There has been no blood in the stools and they have not been excessively pale or difficult to flush away. After he drinks milk or eats gluten-containing foods, his symptoms are worse.

Physical examination reveals a well-looking, afebrile man. There is no obvious lymphadenopathy, his abdominal examination is normal and the remainder of the examination is non-contributory.

The patient is noted to be anaemic with a haemoglobin of 90 (normal is 120-140); the anaemia is hypochromic and microcytic. On checking his iron stores are low but his B12 and folate levels are normal. He has a low calcium and phosphate as well as a low vitamin D. Stool examination microscopy is normal, but Giardia antigen is positive.

He is given a course of tinidazole, but symptoms continued on follow-up 1 month later. In view of this, he is tested for coeliac disease, and tissue transglutaminase antibodies are positive. Upper endoscopy is performed and small bowel biopsies obtained; these show partial villous atrophy consistent with coeliac disease, but no giardia. A bone mineral density scan is performed and he has evidence of osteopenia. He is treated with a gluten-free diet as well as iron, calcium and vitamin D supplements plus folic acid, and has an excellent response with resolution of his diarrhoea. He is advised to maintain a gluten-free diet for life for treatment of coeliac disease.

Villous atrophy can be seen both in giardia and coeliac disease so these conditions can be confused. Testing bone mineral density is important in coeliac disease where a lifelong gluten-free diet is recommended to reduce complications. Patients may develop secondary lactose intolerance (and milk intolerance) with coeliac disease, but this usually recovers after a gluten-free diet is adopted.

Introduction

Chronic diarrhoea can be simply defined as the frequent or urgent passage of unformed stool for at least one month. As with acute diarrhoea (Ch 13), a careful history and physical examination will often help suggest the diagnosis and direct investigations.

History

The clinician needs to determine what the patient means by diarrhoea. The patient should be asked about the frequency and consistency of the stools. Diarrhoea needs to be distinguished from rectal urgency alone or faecal incontinence (Ch 16).

Clues to the cause of the diarrhoea can be obtained from the history and examination (Table 14.1). Small-volume, frequent stools suggest large bowel disease and tenesmus (a constant sense of the need to defecate) suggests rectal involvement. Large-volume, watery stools are consistent with small bowel disease, whereas obvious clinical steatorrhoea with pale, bulky, oily stools that float suggests the presence of small bowel or pancreatic disease.

Table 14.1 Clinical features in chronic diarrhoea

Clinical feature Conditions to consider
Young age Coeliac disease, inflammatory bowel disease, lactase deficiency, irritable bowel syndrome
Oil droplets in stool Pancreatic insufficiency
Previous surgery Bacterial overgrowth, dumping, post vagotomy diarrhoea, ileal resection, short bowel syndrome
Peptic ulcer Zollinger-Ellison syndrome
Medications Laxatives, magnesium antacids, antibiotics, lactulose, colchicine
Frequent infections Immunoglobulin deficiency
Marked weight loss Thyrotoxicosis, malignancy, malabsorption
Arthritis Inflammatory bowel disease, Whipple’s disease, hypogammaglobulinaemia, Yersinia spp.
Hyperpigmentation Whipple’s disease, Addison’s disease, coeliac disease
Fever HIV, inflammatory bowel disease, lymphoma, Whipple’s disease
Flushing Carcinoid syndrome
Chronic lung disease Cystic fibrosis
Neuropathy Diabetes mellitus, vitamin B12 deficiency, amyloidosis
Family history of diarrhoea Colon cancer, coeliac disease, inflammatory bowel disease

The presence of blood may indicate local anal bleeding or other colonic disease. Bright red blood that is separate from the stool is consistent with an anal or rectal cause, but may occur with more proximal colonic disease. Altered blood, or blood with the stool is in keeping with higher colonic bleeding, such as from inflammatory bowel disease or colon cancer (Ch 10).

Symptoms associated with the diarrhoea may also provide valuable information about the nature of the underlying disease process. Weight loss suggests an organic disorder and may be marked with malabsorption, carcinoma or inflammatory bowel disease. Large joint arthritis or sacroileitis suggests inflammatory bowel disease. Yersinia infection and Whipple’s disease can also present with arthritis.

Symptoms of individual nutrient deficiencies (like easy bruisability with vitamin K deficiency, night blindness with vitamin A deficiency, tetany and osteomalacia with vitamin D deficiency and stomatitis, angular cheliosis, glossitis and anaemia with iron and B group vitamin deficiency) not only help separate functional from organic diarrhoea but also may provide aetiological clues.

The presence of a skin rash may suggest coeliac disease (e.g. dermatitis herpetiformis) or inflammatory bowel disease (e.g. erythema nodosum or erythema multiforme). Crampy abdominal pain occurs with diarrhoea of any cause, but pain shortly after eating raises the possibility of partial bowel obstruction (e.g. Crohn’s disease or bowel cancer). Abdominal pain is also a feature of chronic pancreatitis, associated with malabsorption. Abdominal bloating may occur with most forms of diarrhoea but, in association with alternating diarrhoea and constipation, suggests the presence of the irritable bowel syndrome. The duration of symptoms may also be helpful, as diarrhoea occurring over many years is more in keeping with a benign process.

There may be a correlation between diarrhoea and diet. Milk consumption in lactose-intolerant individuals or sorbitol intake (in chewing gum and fruit juices) can cause diarrhoea. Changing to a high-fibre diet may also cause a change in bowel habit with loose stools.

A history of systemic disease may be relevant. Disorders such as diabetes mellitus and hyperthyroidism may present with diarrhoea.

Previous surgical history including gastrectomy (postvagotomy diarrhoea and dumping syndrome), small bowel resection, bariatric surgeries and cholecystectomy must be obtained.

A drug history may identify the cause of diarrhoea; a wide variety of medications have been implicated. Antibiotics and antacids are frequent offenders in this category. Non-steroidal anti-inflammatory drugs (by causing ileal damage and bile salt malabsorption), metformin and several cardiac drugs (antiarrthymics, antihypertensives and diuretics) are other commonly used offenders and should be sought in the history. Alcohol is also a cause of chronic diarrhoea and surreptitious laxative abuse needs to be considered in difficult cases.

A sexual history is important in the evaluation of a chronic diarrhoeal illness, as diarrhoea is a very common symptom in patients with HIV/AIDS. Overseas travel before the onset of diarrhoea may implicate a gastrointestinal infection or, more frequently, a postinfectious irritable bowel syndrome.

The family history should be obtained as inflammatory bowel disease, bowel cancer and coeliac disease have an increased incidence in families.

Assessment

The history and physical examination will often direct the order and nature of investigations.

Categorising the pattern of diarrhoea into osmotic (ceases on fasting), secretory (persists in fasted state), inflammatory (passage of blood) and classical steatorrhoea helps in directing investigations though overlap can occur. (See Figs 14.1 and 14.2.)

image

Figure 14.1 Flow chart 1.

Adapted from Fine, KD, Schiller, LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999; 116:1464.

image

Figure 14.2 Flow chart 2

From Fine, KD, Schiller, LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999; 116:1464.

Approach to Chronic Diarrhoea

In those in whom the diagnosis is not obvious, a variety of factors will influence the order and extent of investigations, especially the age of the patient and the length of the history. A long history suggests a benign illness, although disorders, such as coeliac disease and Crohn’s disease, may not be diagnosed for many years because of subtle symptoms. Conversely, the development of new symptoms in a patient over the age of 40 years would raise concern about the possibility of bowel cancer.

A full blood count and erythrocyte sedimentation rate (ESR) is a simple initial blood investigation and may provide information about anaemia due to iron, folate or vitamin B12 deficiency. It may also show an elevated white cell count or ESR, suggesting the presence of inflammation. The serum albumin will often be low with chronic inflammatory process or with malnutrition.

The stool examination may provide information about parasites, such as Giardia lamblia, and may also document white blood cells implicating inflammation or infection, or red blood cells in bleeding (e.g. carcinoma). The stool weight provides some evidence of the severity of diarrhoea.

Sigmoidoscopy may establish the presence of inflammation or tumours. A biopsy should always be performed in patients with diarrhoea to exclude microscopic or collagenous colitis. Melanosis coli may be obvious macroscopically and will also be demonstrated on biopsy. A colonoscopy requires a full bowel preparation with sedation, but has the advantage of examining the entire bowel length and often the terminal ileum can be intubated as well. Disorders that may require colonoscopy for diagnosis include bowel cancer, polyps, segmental colitis and terminal ileitis.

Radiological investigations that may aid in the investigation of diarrhoea include a plain abdominal x-ray, small bowel series, barium enema, virtual computed tomography (CT) colonography and abdominal CT scan.

If small bowel disease is suspected, a small bowel biopsy (usually performed endoscopically) may provide further information. A disaccharidase assay can be carried out at the same time as a small bowel biopsy and bacterial culture.

Further investigations that may be needed if no diagnosis is reached include stool examination for laxatives and blood tests for thyroid function (thyroid-stimulating hormone) and hormone-secreting tumours (e.g. gastrin and vasoactive intestinal polypeptide).

Malabsorption

The basic physiological problem the body faces in assimilation of food is the passage of nutrients across the limiting cell membrane of the enterocyte. The problem is solved by breaking food particles down to basic components (digestion) and the insertion of special carrier proteins into the absorptive cells to facilitate absorption. The term ‘malabsorption’ is generally used to encompass both impaired digestion and defective absorption. A classification of malabsorption is shown in Box 14.1.

Physiology

Understanding malabsorption requires knowledge of the physiology of normal digestion and absorption.

Clinical Approach to the Patient with Malabsorption

Diagnosis in malabsorption requires firstly suspecting its presence, secondly confirming its existence and thirdly demonstrating the cause (Table 14.2).

Confirming malabsorption

Finding the cause of malabsorption

History

The list of causes of malabsorption (Box 14.2) is daunting, and a thorough history is essential to target investigations. Common causes of malabsorption include coeliac disease, chronic pancreatitis, small bowel bacterial overgrowth and gastric surgery.

A cause may be obvious from the history if gastric surgery or a small bowel resection has been performed or there is known chronic pancreatitis. Childhood diarrhoea, failure to thrive or anaemia may suggest the possibility of coeliac disease. An associated skin rash of dermatitis herpetiformis (Fig 14.3) or a positive family history may also be clues to the diagnosis of coeliac disease.

Abdominal pain, alcohol excess or a history of passing ‘oil’ suggests chronic pancreatitis. Abdominal pain may also be a feature of Crohn’s disease and there is sometimes a positive family history of inflammatory bowel disease. Intestinal lymphoma and mesenteric ischaemia may also present with abdominal pain.

A careful history may elicit drugs that may result in malabsorption including cholestyramine, neomycin, colchicine and cathartics. The history should also be directed towards identifying systemic disorders that may be associated with malabsorption, including AIDS, scleroderma, thyrotoxicosis or diabetes mellitus.

Investigations

The nature and order of investigations carried out is dependent on the history. In many instances a cause will be suggested and investigations can be targeted. For example, upper abdominal pain may suggest pancreatitis, directing investigations towards demonstrating pancreatic disease. Crampy lower abdominal pain and diarrhoea would lead investigations towards exclusion of Crohn’s disease. Specific investigations are set out below.

A plain abdominal x-ray may show pancreatic calcification, which establishes the diagnosis of chronic pancreatitis. An abdominal CT scan is more sensitive in documenting calcification and may show a dilated pancreatic duct or pancreatic mass.

Endoscopic retrograde cholangiopancreatography will document changes of chronic pancreatitis with dilated and/or irregular ducts. A magnetic resonance pancreatogram is less invasive and may also document typical pancreatic duct changes.

An endoscopic ultrasound can detect chronic pancreatic disease with changes categorised as parenchymal and ductal. Parenchymal changes include increased lobulation and the presence of calcification whereas the ductal changes include dilated ducts, hyperechoic ductal margins and prominent branch ducts.

It is important to note that structural changes seen on imaging do not necessarily translate to pancreatic insufficiency since individuals with a lot of changes on imaging may have no insufficiency, and the reverse also is true.

Direct tube tests such as the secretin stimulation test remain the ‘gold standard’ for the assessment of exocrine function, but are seldom used today. They involve placement of a tube into the second part of the duodenum, the administration of secretin or cholecystokinin and the measurement of bicarbonate or enzymes in the aspirated duodenal juice. These tests are expensive to perform and uncomfortable for the patient, and may yield false positive results if duodenal collection of juice is inadequate. Alternative non-invasive tests for pancreatic function have been developed and include the bentiromide test, the pancreolauryl test, the faecal chymotrypsin assay and the faecal elastase assay. None of these tests has achieved sufficient sensitivity or specificity to attract widespread use, but this is a developing area.

In children with malabsorption, a sweat test is required to exclude cystic fibrosis.

If small bowel disease is suspected, a small bowel biopsy at upper endoscopy is usually performed in a patient with unexplained malabsorption. This may be preceded by serological tests for coeliac disease (see later). In addition to the diagnosis of coeliac disease (a common cause of malabsorption), rare causes of malabsorption such as lymphangiectasia and Whipple’s disease can also be detected. Giardia lamblia trophozoites may sometimes be visible on routine histology and a disaccharidase assay can be performed.

Barium studies of the small bowel may define defects that give rise to malabsorption, such as strictures, diverticula or fistulae. Small bowel endoscopy or wireless capsule endoscopy can be useful in difficult cases.

Small bowel bacterial overgrowth can be reliably detected only by the measurement of viable counts of bacteria in fasting proximal small intestinal aspirates obtained at upper endoscopy. This requires small intestinal intubation as well as a specialist unit experienced in anaerobic bacterial culture. The presence of an elevated serum folate and a reduced B12 is a laboratory clue to bacterial overgrowth since bacteria produce folate and utilise B12.

A variety of indirect tests have evolved for the diagnosis of small bowel bacteria overgrowth. These include the 14C glycocholate test, which relies upon bacterial deconjugation of bile acid and an increase in 14CO2. This test has a high false-positive and false-negative rate.

The 14C-D-xylose breath test relies upon bacterial metabolism of 14C-D-xylose by bacteria in the proximal small intestine. 14CO2 is formed, and is then absorbed and excreted in the breath. Although some reports suggest that this test has a high sensitivity and specificity, others have been unable to substantiate this claim. This test’s role in the investigation of small intestinal bacterial overgrowth remains unclear.

Other indirect tests, including the lactulose breath test, glucose breath hydrogen test and rice breath hydrogen test, all have unacceptable sensitivity and specificity levels.

Ileal absorptive function can be determined by Schilling’s test performed with intrinsic factor in three stages (without intrinsic factor, with intrinsic factor and after a course of treatment), or with a SeHCAT (Se-labelled homocholic acid taurine) test. Vitamin B12 and bile acids are absorbed in the terminal ileum. The Schilling test is frequently abnormal with and without intrinsic factor in terminal ileal disease. Vitamin B12 absorption in pernicious anaemia corrects with intrinsic factor. SeHCAT is the taurine conjugate of a synthetic bile acid and the test includes measurement of body Se retention after the administration of SeHCAT. Retention of less than 50% after 3 days suggests bile acid malabsorption.

Disorders that may Cause Chronic Diarrhoea or Malabsorption

Coeliac disease

Coeliac disease (gluten-sensitive enteropathy) is a disorder of the small intestine caused by sensitivity to gluten, a protein component of cereals found in wheat, rye, barley, triticale and possibly oats. Exposure to gluten causes small bowel damage characterised by inflammation and villous trophy.

Diagnosis

The diagnosis of coeliac disease is made by documenting the typical mucosal changes (Fig 14.4) on small bowel biopsies, which are usually obtained at endoscopy. Multiple biopsies should be obtained from the second part of the duodenum. It is important to ensure that the patient is on a gluten diet before performing a biopsy, otherwise an adequate challenge of gluten (the equivalent of four slices of bread per day for 4–6 weeks) should be administered and the development of positive serology checked before performing a biopsy. Small bowel biopsies do, however, have their limitations (see Box 14.3).

image

Figure 14.4 Subtotal villous atrophy showing total absence of villi and a corresponding increase in depth of the crypts, producing an apparently increased mucosal thickness.

Illustration based on photomicrograph from Misiewicz JJ, Bantrum CI, Cotton PB, et al. Slide atlas of gastroenterology. London: Gower Medical Publishing; 1985, with permission.

Serological tests, useful for screening in coeliac disease are now available (Table 14.3). Tissue transglutaminase appears to be the target antigen detected by the endomysial antibody assay.

Table 14.3 Serological tests in coeliac disease

Test Sensitivity (%) Specificity (%)
IgA AGA 75–90 82–95
IgG AGA 69–85 73–90
EMA 85–90 97–100
TGA 93–96 99–100

AGA = antigliadin antibody; EMA = endomysial antibody; TGA = tissue transglutaminase antibody.

Note that up to 5% of individuals with coeliac disease are IgA deficient and will have a false-negative screening test to IgA antigliadin antibody, endomysial antibody and transglutaminase antibodies.

A diagnosis of coeliac disease should not be made on serological tests alone and a small bowel biopsy is always required for confirmation.

Screening tests are useful for those with a low probability of coeliac disease and to monitor the response to a gluten-free diet.

In individuals with suspected coeliac disease but negative serology, it is worth repeating the test with another laboratory and ensuring that the patient is not IgA deficient. The possibility of a false-positive biopsy should also be borne in mind. Those with true negative serology and definite biopsy-proven coeliac disease will require monitoring of their response with clinical and laboratory parameters; it is worth repeating the biopsy at a later stage.

It is worth following first-degree relatives who share the HLA genotype but whose serology is negative and repeating the serology in 2 years. If the serology becomes positive a small bowel biopsy is indicated.

Treatment

The treatment of coeliac disease requires a lifelong gluten-free diet and the exclusion of wheat, rye, barley and triticale from the diet. It is not clear whether oats cause disease, but they should be avoided as oats are often contaminated with small amounts of gluten from wheat barley.

Patients should be educated in the importance of maintaining a gluten-free diet and referred to a dietician who is experienced in advice to patients with coeliac disease.

Clinical improvement occurs in 2–6 weeks in most patients. Serological improvement takes 4–6 weeks and histological recovery in up to 2 (sometimes more) years.

The commonest cause of failure to respond is due to non-compliance. The other causes of persistence of symptoms include lactose intolerance, pancreatic insufficiency, small intestinal bacterial overgrowth, microscopic colitis, irritable bowel syndrome and wrong diagnosis. True refractory disease and development of lymphoma are the rarer but important possibilities. The treatment options for refractory disease include steroids (including budesonide), immunosuppresives, infliximab, hypoallergenic elemental enteral feeds, parenteral nutrition, cladribine, alemtumuzab, stem cell transplantation and anti-IL-15.

Malignancy risk is elevated although not as high as previously thought with an increased incidence of gastrointestinal malignancy: oropharyngeal cancer, oesophageal squamous cell cancer, small bowel adenocarcinoma and enteropathy-associated T-cell lymphoma.

Immunological

Gynaecological

Obstetric

Liver

Gastrointestinal

Endocrine

Haematological

Cardiac

Miscellaneous

Short bowel syndrome

The small bowel intestine has a functional reserve of around 40–50% and when disease or resection exceeds this, diarrhoea and malabsorption results. As well as the extent of resection, the site of resection (jejunum or ileum), the loss of ileocaecal valve and the loss of the colon will determine the severity of symptoms.

Small intestinal bacterial overgrowth

The small intestine is usually relatively sterile with bacterial colony counts being less than 10 per millilitre of jejunal fluid. This relative sterility is maintained by normal small intestinal motility, gastric acidity, surface mucus and mucosal immunity, including secretory IgA.

Small bowel bacterial overgrowth may lead to mucosal damage and malabsorption of certain nutrients. Patients may be asymptomatic or have abdominal bloating, watery diarrhoea and weight loss.

Multiple mechanisms are responsible for malabsorption, including intestinal mucosal damage with loss of disaccharidases, and bacterial deconjugation of bile salts. Vitamin B12 malabsorption is common, due to bacterial utilisation of this vitamin. The production of toxins may be important in certain liver diseases such as cirrhosis and non-alcoholic steatohepatitis.